Theralink Technologies, Inc. (THER)
OTCMKTS
· Delayed Price · Currency is USD
0.00
0.00 (0.00%)
At close: Dec 30, 2024
Theralink Technologies Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 0.64 | 0.61 | 0.57 | 0.51 | 0.18 | - | Upgrade
|
Revenue Growth (YoY) | 16.76% | 6.85% | 12.32% | 178.99% | - | - | Upgrade
|
Cost of Revenue | 0.25 | 0.2 | 0.36 | 0.25 | 0.1 | - | Upgrade
|
Gross Profit | 0.39 | 0.4 | 0.2 | 0.26 | 0.08 | - | Upgrade
|
Selling, General & Admin | 8.1 | 9.15 | 11.84 | 5.82 | 3.43 | 1.6 | Upgrade
|
Research & Development | - | - | - | - | - | 0.17 | Upgrade
|
Operating Expenses | 8.1 | 9.15 | 11.84 | 5.82 | 3.43 | 1.77 | Upgrade
|
Operating Income | -7.71 | -8.74 | -11.64 | -5.57 | -3.36 | -1.77 | Upgrade
|
Interest Expense | -19.61 | -16.91 | -1.09 | -0.12 | -0.03 | -1.8 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | - | -0.02 | 0.05 | - | Upgrade
|
Other Non Operating Income (Expenses) | 14.07 | 0.62 | - | - | 0.01 | -5.76 | Upgrade
|
EBT Excluding Unusual Items | -13.26 | -25.03 | -12.73 | -5.71 | -3.33 | -9.32 | Upgrade
|
Gain (Loss) on Sale of Investments | -0 | -0 | -0.01 | -0 | -0.01 | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | - | - | Upgrade
|
Asset Writedown | -0.24 | -0.24 | - | - | - | - | Upgrade
|
Other Unusual Items | - | -5.63 | - | 0.23 | 0.17 | -0.08 | Upgrade
|
Pretax Income | -13.5 | -30.91 | -12.74 | -5.47 | -3.17 | -9.4 | Upgrade
|
Earnings From Continuing Operations | -13.5 | -30.91 | -12.74 | -5.47 | -3.17 | -9.4 | Upgrade
|
Net Income | -13.5 | -30.91 | -12.74 | -5.47 | -3.17 | -9.4 | Upgrade
|
Preferred Dividends & Other Adjustments | - | 0.04 | 0.24 | 1.17 | 2.01 | - | Upgrade
|
Net Income to Common | -13.5 | -30.95 | -12.98 | -6.64 | -5.18 | -9.4 | Upgrade
|
Shares Outstanding (Basic) | 6,151 | 6,151 | 5,881 | 5,370 | 85 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 6,151 | 6,151 | 5,881 | 5,370 | 85 | 0 | Upgrade
|
Shares Change (YoY) | 2.01% | 4.60% | 9.53% | 6242.72% | 17008.05% | - | Upgrade
|
EPS (Basic) | -0.00 | -0.01 | -0.00 | -0.00 | -0.06 | -19.00 | Upgrade
|
EPS (Diluted) | -0.00 | -0.01 | -0.00 | -0.00 | -0.06 | -19.00 | Upgrade
|
Free Cash Flow | -5.12 | -5.94 | -5.52 | -4.92 | -4 | -1.17 | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.05 | -2.37 | Upgrade
|
Gross Margin | 61.41% | 66.70% | 36.02% | 50.77% | 42.47% | - | Upgrade
|
Operating Margin | -1213.62% | -1440.47% | -2049.64% | -1100.86% | -1852.24% | - | Upgrade
|
Profit Margin | -2124.13% | -5100.06% | -2285.94% | -1312.94% | -2856.27% | - | Upgrade
|
Free Cash Flow Margin | -805.21% | -978.62% | -972.22% | -972.43% | -2208.42% | - | Upgrade
|
EBITDA | -7.51 | -8.53 | -11.45 | -5.38 | -3.26 | -1.77 | Upgrade
|
D&A For EBITDA | 0.2 | 0.21 | 0.19 | 0.19 | 0.1 | 0 | Upgrade
|
EBIT | -7.71 | -8.74 | -11.64 | -5.57 | -3.36 | -1.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.